Find solutions through research
Research and VIDO-InterVac
VIDO-InterVac’s research includes a broad range of infectious diseases and "platform technologies" applicable to a broad spectrum of diseases or species.
Our capabilities for testing vaccines against Containment Level 2 (CL2) diseases range from small rodent trials to large animal disease models.
When InterVac is operational in 2012, our capabilities will expand substantially to include Containment Level 3 diseases.
Science Management Team
|
Associate Director, Research |
Core Research & Contract Research |
|
Vaccine Formulation & Delivery |
Viral Vaccine Development |
|
Bacterial Vaccine Development |
Clinical Research and GMP |
Research Themes
VIDO-InterVac research programs are organized into several themed areas:
- Bacterial Vaccine Development
- Vaccine Formulation & Deliver
- Viral Vaccine Development
- Clinical Research and GMP
- Core Research and Contract Research
Inquiries about research programs can be directed to Dr. Volker Gerdts, Associate Director for Research at (306) 966-1513 or volker.gerdts@usask.ca
